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Abstract
In general, an initial diagnosis of HIV is likely to be correlated with the onset of HIV stigma. HIV-positive
individuals are likely to internalize stigma, may suffer from psychosocial issues, or engage in maladaptive
behaviors to cope with the diagnosis. Internalized stigma stems from fear of stigmatization also known as felt
stigma. The current study examined the impact of HIV felt stigma on overall health and success of HIV
prevention behaviors among 370 participants living with HIV and receiving care at an urban HIV clinic in
Kenya. An 18-item instrument was cross culturally adapted to measure felt stigma. Descriptive and logistic
regression analyses examined the data. Findings indicate that 25.9% (n = 96) of participants who reported ex-
periencing high levels of felt stigma related to other people’s attitudes toward their condition, ostracizing, and a
disruption of their personal life, were likely to not adhere to prescribed HIV medication and not disclose their
HIV serostatus to one other person. Those who also experienced felt stigma related to a disruption of their
personal lives while mediated by depression were likely to report poor overall health. Findings support having
HIV clinics and interventions develop relevant HIV prevention strategies that focus on the emerging dimensions
of felt stigma which can significantly impact disclosure of serostatus, medication adherence, and overall health.
Introduction
In sub-Saharan Africa, documented evidence reports adecline in the number of new HIV infections from a peak of
2.2 million in 2001 to 1.9 million in 2010.1,2 Nevertheless, South
Africa reportedly bears the severity of the epidemic with 5.6
million people living with HIV as of 2010.3 In Kenya, there has
been a decline in HIV incidence rates although HIV prevalence
rates appear to have stabilized at high levels.4 For example, in
Nyanza Province Western Kenya, reports from male circum-
cision programs indicate that almost 2000 new HIV infections
were avoided by program participants in the year 2010.1
A national AIDS strategic plan in 2006–20105 was launched
to address HIV prevention challenges in Kenya such as neg-
ative serostatus partners in discordant relationships or ne-
glected marginal groups at increased risk of acquiring HIV.6
To enhance the effectiveness of HIV prevention strategies, the
Kenya National AIDS Control Council [NACC]6 recommends
involving political leaders and incorporating local culture and
traditions such as including traditional midwives in preven-
tion of mother-to-child transmission programs. The plan
aimed at increasing universal access to HIV care, reducing
burden of care in households and reducing AIDS mortality.5
Particular to stigma, an HIV stigma strategic plan was
launched in 2008 in Kenya utilizing religious leaders along-
side health care workers. Consequently, stigma has report-
edly decreased via advocacy and social marketing messages.5
Such findings provide some hope but there is room for more
work in order to eradicate HIV stigma in Kenya.
HIV-related stigma stems from personal beliefs or situa-
tional cues implying that an individual has deviated from
societal norms by acquiring HIV and should be treated dif-
ferently; leads to labeling, ostracizing, discriminating, or ste-
reotyping of people living with HIV/AIDS (PLWHA).7–12
Given the discrediting nature of HIV/AIDS because it is a
sexually transmitted disease or associated with certain group
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memberships such as commercial sex workers, PLWHA are
likely to internalize stigma and may suffer from low self-es-
teem, depression, anxiety, unproductivity or engage in ma-
ladaptive behaviors to cope.7,9,10,13,14
Internalized stigma stems from fear of stigmatization,
which is termed as felt stigma.15,16 Ultimately, felt stigma can
negatively impact PLWHA’s overall health and the success of
HIV prevention behaviors such as condom use, adherence to
prescribed medication regimen, and disclosure of serostatus
to others.10,17–19
In order to minimize HIV felt stigma and enhance the up-
take of aforementioned HIV prevention behaviors among
PLWHA in Kenya, it is important to incorporate local culture
and traditions in HIV prevention strategies as recommended
by NACC.6 Inclusion of culture and tradition may provide
insight into understanding contexts ‘‘within which these fears,
blames and behaviors are expressed.’’20(p410)
Cultural contexts include a network of group affiliations
associated with family, friends, religious institutions, work-
place, government etc. Simmel21(p163) could not have said it
better when he suggested that, ‘‘. society arises from the
individual and that the individual arises out of association.’’
Thus, group perspective is necessary in addressing HIV
stigma that emerges from shared values, beliefs, norms at the
individual, familial and societal levels, e.g., women who are
seropositive are deemed promiscuous and immoral and
blamed for infecting the man.22,23 Attention should, therefore,
shift to understanding the network of relationships between a
PLWHA and the aforementioned groups within his cultural
context instead of placing the burden of behavior change on
the individual.24
In summary, addressing stigma, particularly felt stigma,
in HIV prevention is important because of the documented
evidence highlighting that stigmatized individuals may per-
ceive themselves as outcasts in their communities, engage in
maladaptive behaviors (alcohol abuse or unprotected sex) as a
coping mechanism and be unproductive.7,9,10,13–15 Other
PLWHA may suffer from mental health issues especially if
stigmatized individual perceives negative actions by other
individuals as legitimate. Consequently, such an individual
may birth negative concepts about self-based on the negative
attitudes of others which may negatively impact overall
health status.9,10
The current study examined the impact of HIV felt stig-
ma on the overall health and success of HIV prevention
behaviors among PLWHA in an urban city in Kenya. An 18-
item instrument was cross culturally adapted and utilized
to measure felt stigma. Seven items addressing culturally
relevant beliefs, values, traditions, and attitudes likely to be
perceived and internalized by PLWHA as a response to
their being HIV positive20,25–27 were added to the original
11-item HIV felt stigma instrument.28 The original 11-item
tool was also an enhanced version of a 13-item HIV stigma
measure.29
Methods
Data collection
Study protocols were approved by the Ethics & Scientific
Review Committee at the African Medical Research Foun-
dation (AMREF) in Nairobi and the Institutional Review
Board at Indiana University-Bloomington.
Study participants (n = 370) were recruited from a volun-
tary testing and counseling (VCT) clinic during routine clinic
visits, over a period of 3 ½ weeks in 2011, in a resource-limited
urban area in Kenya. Eligible participants were either male or
female, living with HIV/AIDS, between the ages of 18–60
years old, were receiving HIV/AIDS related and other health
services at the clinic, and were from a diverse ethnic and so-
cioeconomic background.
Potential participants attending the VCT clinic were ap-
proached by the researcher at the waiting area as they waited
to be seen by a medical officer. A designated medical officer
was on hand every morning to identify for the researcher
HIV-positive individuals, primarily those who had medical
appointments at the clinic on a given day. After participants
were screened for eligibility they were recruited, taken to a
private room, and asked to complete a researcher-administered
questionnaire in both English and Swahili, both of which are
national languages in Kenya.
Participation was voluntary and participants provided
consent for their responses to be used to inform research. The
VCT clinic provides health services pertaining to: HIV infec-
tion testing and counseling, antiretroviral therapy (ART)
medication, preventing mother-to-child transmission of HIV
(PMTCT) services, tuberculosis prevention, and maternity
among others.
Measures
Demographic, sexual behavior, and HIV-related vari-
ables. Participants completed measures addressing demo-
graphics (age, gender, education status, number of children at
home, employment status, religion, tribal affiliation, income);
HIV-related characteristics (disclosure of serostatus, duration
of HIV serostatus, social support); and sexual behavior (con-
dom use the most recent time they had sex and number of
sexual partners in the past 3 months).
Medication adherence scale. A four-item scale was
adapted from Morisky et al.30 and has a 5-point scale response
options ranging from 1=never to 5= always. The scale is re-
ported as a reliable and valid measure for diagnosing com-
prehension levels of medical information in order to address
any misinformation or misbeliefs and examining behaviors
related to adherence of prescribed medication. 30
HIV felt stigma instrument. Felt stigma was measured
utilizing a cross culturally adapted 18-item tool. Felt stigma
symptoms were based on a 30-day period using five response
items, 1=never to 5= always. This instrument has previously
been used in HIV clinics the United States28 and western
Kenya.31–33
Prior to conducting analyses for this article, factor analyses
of the felt stigma tool were conducted; four factors with a total
of 10 items emerged with a 45% total explained variance. All
factor loadings had a 0.50 cutoff point and did not cross-load.
Factor one, public attitudes, had three items loaded on it
with item factor correlations ranging from 0.628 to 0.547 and
had the greatest percentage variance (31.01%). The three items
measured the extent to which PLWHA were affected by
public beliefs and attitudes toward their serostatus. Factor
two, ostracize, had three item loadings with item factor cor-
relations ranging from 0.784 to 0.604 and explained variance
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of 6.63%. Items examined stigmatizing feelings related to
avoidance, looked down upon, or treated differently.
Factor three, discrimination, with a 4.56% explained vari-
ance had two item loadings with item factor correlations be-
tween 0.842–0.734. Items examined felt stigma related to other
people not touching PLWHA or eating food prepared by
PLWHA. Factor four, personal life disrupted, also had two
item loadings with item factor correlations between 0.612–
0.516 and explained variance of 2.88%. Items measured the
extent to which PLWHA had experienced a disruption of their
home and work life due to the fear of stigmatization at home
or place of employment.
The overall felt stigma tool revealed a high internal con-
sistency (a= 0.864) while the emerging four factors also had
high internal consistency with a coefficients ranging from
0.675 to 0.799.
The Patient Health Questionnaire-9 (PHQ-9). PHQ-934,35
was utilized to measure depressive symptoms because stigma
is a constellation of psychological distress symptoms, which
may mediate the impact of HIV stigma on likelihood of en-
gaging in HIV prevention behaviors.36 Depression is docu-
mented to have an association with a diagnosis of HIV
infection and may increase PLWHA perception of HIV stig-
ma.36–38 The 9-item tool measured depression symptoms ex-
perienced over a 2-week period. It is made up of a 4-point
Likert scale ranging from 0 =not at all to 3=nearly every day
and summed up across 9 severity items (minimal, mild,
moderate, moderately severe, severe) ranging from 0 to 27. In
this study, PHQ-9 had a satisfactory level of internal consis-
tency (a= 0.702). The instrument has been utilized among
other HIV-positive individuals.31,32,34,35,39–42
General health rating. The general rating measure was
adopted from the SF-1243 instrument to measure overall
health utilizing response scales ranging from ‘‘excellent’’ (high
score of 1) to ‘‘poor’’ (low score of 5).
Data analysis
All data analyses were conducted using SPSS version 19.0
(SPSS Inc., Chicago, IL).44 Descriptive tests examined demo-
graphic and HIV-related characteristics stratified by gender.
Logistic regression analyses were conducted where five ca-
tegories of independent variables (four HIV felt stigma di-
mensions and depression) were entered to determine which of
them would predict a negative impact on each dependent
variable (medication adherence, disclosure of serostatus to
one other person, condom use) and overall health. HIV felt
stigma factor scores, depression and dependent variables
were recoded into categorical binary response variables (0, 1)
to enable the analyses.
Depression sum scores ranged from 0 to 27 across severity
categories: minimal= 1, mild= 2, moderate= 3, moderately se-
vere= 4, and severe= 5. These categories were then collapsed
and recoded into two binary categories (mild depression, 1
through 3= 0 and severe depression, 4 through 5= 1). Felt
stigma sum scores were also collapsed and recoded into two
binary categories whereby low levels included sum scores of 39
or less while high levels had sum scores of 40 or higher.
The general health rating response levels (excellent = 5, very
good = 4, good= 3, fair = 2, poor = 1) were collapsed into two
binary categories: optimal, 5 through 3 = 0 and poor, 2
through 1= 1.
Results
Participant characteristics
Data were analyzed for 370 participants. The sample had a
mean age of 37.06 years (standard deviation [SD]= 8.61),
51.1% were married, and 61.1% were female (Table 1). The
highest level of education for most of the participants was
‘‘standard 4–8’’ (48.1%) and ‘‘form 3–4’’ (24.3%), which is
equivalent to the American system of middle school grades
6–8 and high school grades 9–12. Due to the nature and
location of the HIV clinic, participants were deemed low
income since 48.6.5% (n= 180) were unemployed while those
employed earned an average monthly income of 2,000–4,000
Kenya shillings (19.7%, n= 73) which is the equivalent of US
$24-$50 (Table 1).
HIV-related characteristics
All the study participants were HIV positive and living
with the infection for a median time of 3 years. With regard to
the method of HIV transmission, the majority of females
(56.5%, n= 126 p< 0.05) and males (48.3%, n = 69 p < 0.05) re-
ported acquiring the infection from heterosexual intercourse.
Regarding knowledge of a sexual partner’s serostatus, 31.4%
(n= 116) of the participants indicated their primary sex part-
ner was living with HIV. Majority of the participants (62.4%,
n= 231) reported they were experiencing optimal health.
Pertaining to disclosure of serostatus to one other person(s),
most females (46.2%, n= 103) had disclosed their HIV ser-
ostatus to their immediate family including brother(s), sis-
ter(s), and parent(s) while a majority of males (65.0%, n= 93)
had disclosed to their spouses (Table 2).
Sexual behaviors
When asked to report condom usage the previous time they
had sex, more men reported higher rates of condom use
compared to women (90 versus 85; p< 0.000). With regard to
reporting the number of sexual partners over a 3-month pe-
riod, majority of females (45.3%, n= 101) and males (63.6%,
n= 91) reported having sexual relations with only one partner
whereas 33.2% (n= 123) participants reported no sexual rela-
tions.
Medication adherence
Overall, most of the participants reported taking their
prescribed HIV medication. Majority reported they had not
forgotten to take their medication (73.0%, n = 197), were never
careless at times to take their medication (83.0%, n = 224),
never stopped taking their medication even when they felt
better (94.4%, n = 255) and never stopped taking their medi-
cation even when they felt worse (94.2%, n = 258; Table 3). This
measure also revealed a satisfactory level of internal consis-
tency (a = 0.626).
Overall health
When asked to report on their overall health, 62.4%
(n= 231) of the participants deemed their health at an optimal
level.
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Table 1. Participant Characteristics by Gender
Female (226) Male (144)
Variable Mean SD Mean SD
Age (19–60) 37.06 8.61 41.54 7.86
Years living with HIV 4.10 3.76 3.47 2.83
n % n % p < 0.05
Education 0.008*
None/didn’t attend school 21 9.3 4 2.8
Standard 1–3 9 4.0 3 2.1
Standard 4–8 116 51.3 62 43.4
Form 1–2 28 12.4 16 11.2
Form 3–4 41 18.1 49 34.3
Technical school 2 0.9 4 2.8
University 4 1.8 2 1.4
Other 2 0.9 2 1.4
Tribe group 0.251
Luhya 68 30.1 34 23.8
Luo 55 24.3 46 32.2
Kamba 29 12.8 16 11.2
Bukusu 21 9.3 10 7.0
Kikuyu 14 6.2 14 9.8
Kisii 14 6.2 5 3.5
Relationship 0.000*
Married 78 34.5 111 77.6
Divorced 39 17.3 8 5.6
Single 33 14.6 9 6.3
Significant other/partner 17 7.5 4 2.8
Widow/er 54 23.9 9 6.3
Raise children 0.196
Yes 198 87.6 126 88.1
No 12 5.3 6 4.2
Have no children 12 5.3 4 2.8
Identify with religion 0.175
Yes 216 95.6 136 95.1
No 6 2.7 7 4.9
Employment 0.028*
No 124 54.9 56 39.2
Yes 58 25.7 52 36.4
Other 31 13.7 21 14.7
Average earnings 0.000*
Less than ksh 1,999 16 7.1 7 4.9
ksh 2,000–4,999 53 23.5 20 14.0
ksh 5,000–10,999 9 4.0 31 21.7
ksh 11,000–20,999 4 1.8 10 7.0
ksh 21,000–30,999 2 0.9 5 3.5
ksh 31,000 and above 2 0.9 2 1.4
Education USA Education System Equivalent
Standard 1–3 Elementary school (up to 3rd grade)
Standard 4–8 Middle school (up to 8th grade)
Form 1–2 Lower level high school (up to sophomore level)
Form 3–4 Higher level high school (up to senior level)
Technical school Community college
University Four-year university
Average earnings/month USA Currency Equivalent
Less than ksh 1,999 Less than $24
ksh 2000–4,999 $24–$50
ksh 5,000–10,999 $50–$130
ksh 11,000–20,999 $130–$240
ksh 21,000–30,999 $250–$370
ksh 31,000 and above $370 and above
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HIV felt stigma and depression
Only a fair proportion of the participants reported experi-
encing high levels of stigma (25.9%, n= 96) compared to 73.5%
(n = 272) who reported experiencing low levels of HIV felt
stigma. Similarly, only a few participants reported severe
depression (14.3%, n = 53) in comparison to 84.9% (n = 314)
who reported mild depression.
Impact of HIV felt stigma mediated by depression
on HIV prevention behaviors
Using the criterion a= 0.05, depression and personal life
disrupted (factor 4) significantly predicted an impact on
overall health; ostracize (factor 2) significantly predicted an
impact on disclosure of serostatus; and public attitudes (factor
1) and personal life disrupted (factor 4) significantly predicted
an impact on medication adherence (Table 4).
With regard to overall health, participants who reported
experiencing depressive symptoms were more likely, than
those not experiencing those symptoms, to have poor health
(odds ratio [OR] = 6.234; 95% confidence interval [CI]: 2.95,
13.16, p < 0.05), controlling for all other variables in the model.
Participants experiencing felt stigma related to a disruption of
their personal lives were also more likely, than those not ex-
periencing that kind of felt stigma, to have poor health
(OR = 1.779; 95% CI: 1.03, 3.06, p< 0.05), controlling for all
other variables in the model (Table 4).
Where disclosure of serostatus to one other person is con-
cerned, participants who indicated experiencing felt stigma
related to being ostracized we more likely, than those not
experiencing those symptoms, to not disclose their serostatus
to one other person (OR = 2.139; 95% CI: 1.02, 4.48; p < 0.05),
controlling for all other variables in the model (Table 4).
With regard to medication adherence, participants experi-
encing felt stigma related to public attitudes were more likely,
than those not experiencing that kind of felt stigma, to not
adhere to prescribed medication regimen (OR = 2.341; 95% CI:
1.24, 4.40, p< 0.05), controlling for all other variables in the
model. Participants experiencing felt stigma related to a dis-
ruption of their personal lives were also more likely, than
those not experiencing that kind of felt stigma, to not adhere
to prescribed medication regimen (OR = 2.125; 95% CI: 1.22,
3.68, p< 0.05), controlling for all other variables in the model
(Table 4).
Discussion
The purpose of the study was to examine the extent to
which HIV-related felt stigma would impact overall health
and targeted HIV prevention behaviors (condom use, dis-
closure of HIV serostatus and adherence to prescribed HIV
medication) among PLWHA in an urban city in Kenya. The
support of the psychometric assessment of the felt stigma
measure suggests that the instrument could have predictive
capacity in examining the relationship between stigma and
HIV prevention behavioral outcomes.
Findings indicate that the fair proportion of participants
who reported experiencing felt stigma related to other
people’s attitudes towards their condition, ostracizing and
a disruption of their personal life, were likely to not ad-
here to prescribed HIV medication and not disclose their
HIV serostatus to one other person. These findings sup-
port documented evidence which highlights that stigma
significantly impacts PLWHA because it may (1) interfere
with disclosure of serostatus, e.g., disclosure may affect
their relationships with family, friends, coworkers or (2)
interferes with their seeking HIV/AIDS care services, e.g.,
not adhere to their medication regimen to mitigate side
effects such as weight loss; and (3) can lead to an increase
in HIV transmission, e.g., PLWHA on antiretroviral
medication may not exhibit physical symptoms resulting
in their engaging in risky sexual behaviors such as
PLWHA avoiding using condoms to prevent detection of
serostatus.12,18,19,45
Additionally, those who experienced felt stigma related to a
disruption of their personal lives and mediated by depressive
symptoms, were likely to have poor overall health. Research
reports that when a stigmatized individual perceives negative
actions by other individuals as legitimate, their mental health
could be affected,46 e.g., through depressive symptoms that
could possibly have a negative impact on their overall health.
Depression may increase PLWHA perception of HIV stigma
especially when such an individual suffers from psychologi-
cal issues likely to interfere with their perception of self.36–38
Table 2. Disclosure Patterns by Gender
Female Male
n % n % pa
Anyone 169 75.8 110 76.9 0.860
Spouse 71 31.8 93 65.0 0.203
Children 49 22.0 22 15.4 0.017a
Immediate family 103 46.2 43 30.1 0.046a
Friend 59 26.5 30 21.0 0.071
Employer 13 5.8 7 4.9 0.242
Elder 12 5.4 7 4.9
Uncle/aunt 27 12.1 18 12.6
People at church 16 7.2 8 5.6
Grandparent 7 3.1 7 4.9
Neighbor 25 11.2 12 8.4
ap < 0.05
Table 3. HIV Medication Adherence
Never = 0 Rarely = 1 Sometimes = 2 Often = 3 Always= 4
Variable (n = 270) n (%) n (%) n (%) n (%) n (%)
Do you ever forget to take your medications? 197 (73.0) 54 (20.0) 9 (3.3) 7 (2.6) 0
Are you careless at times about taking your medications? 224 (83.0) 32 (11.9) 11 (4.1) 1 (0.4) 0
When you feel better, do you sometimes stop taking your
medications?
255 (94.4) 10 (3.7) 3 (1.1) 1 (0.4) 0
Sometimes if you feel worse when you take your medications,
do you stop taking them?
254 (94.1) 7 (2.6) 7 (2.6) 1 (0.4) 0
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With regard to the targeted behavioral outcomes, majority
of the participants reported disclosing their serostatus to one
other person and taking their prescribed HIV medication.
Participant disclosure patterns suggest that participants dis-
closed to those with whom they were comfortable. Research
reports that disclosure of serostatus is selective among
PLWHA given the need for social support, to prevent HV
transmission to sexual partners and fear that disclosure can
interfere with varied things such as employment opportuni-
ties, marriage plans, ability to have children with a spouse or
confidentiality.18,47,48
To minimize the spread of HIV infection, disclosure of
serostatus to sexual partners is critical. In this study, disclo-
sure patterns show that more male participants disclosed
their status to their spouses unlike female participants. These
findings are similar to a study that examined disclosure rea-
sons for HIV positive individuals. That study found that a
prevailing reason for nondisclosure to sexual partners among
females was ‘‘fear of abandonment.’’49(p679) Such findings are
concerning and HIV interventions can focus on empowering
women, e.g., by training them in condom negotiation skills, to
enhance disclosure and minimize HIV transmission to spou-
ses if we assume they are also their sexual partners.
In terms of medication adherence, majority of the partici-
pants did report taking their medication as prescribed. This
finding is encouraging given that access to antiretroviral
medication is reported to have increased in sub-Saharan
Africa50 and contributed to a reduction in HIV/AIDS related
morbidity and mortality across the globe.51 However, we
need to be cautious when interpreting these findings given the
self-reported nature of the data and that the medication ad-
herence information provided by the participants was not
cross-checked with patient records.
With regard to condom use, approximately one quarter of
the sample reported use of condoms during sexual relations.
More males reported using condoms compared to females.
The low response rate related to condom use can be attrib-
uted to: (1) stigma feelings brought on by the fear of rejection
from a sexual partner; (2) the sensitive nature of the infor-
mation solicited or; (3) that maybe only a few participants
were engaging in sexual relations. Nevertheless, study
findings support the need for HIV clinics and interventions
to develop relevant HIV prevention strategies targeting
female PLWHA to enhance their condom negotiation skills
and serostatus disclosure to their sexual partners. On an-
other hand, most of the participants who were having sexual
relations reported engaging with only one partner. Such
findings are encouraging given the documented evidence
that having multiple partners increases the likelihood of
spreading HIV infection. Future research may need to
speculate whether social desirability had any role to play in
the participants reporting engaging in sexual relations with
only one partner.
Although the sample is highly selective given that partici-
pants were recruited from an HIV clinic where they had been
exposed to social support groups and counseling, having only
a fair proportion of participants reporting experiencing HIV
felt stigma is a step in the right direction. The data does not
allow us to definitively assert that social support groups and
counseling resulted in the low levels of HIV felt stigma.
However, social support in the form of faith, friendships,
family and so forth, is documented to be a buffer for stigma
among those who are reportedly stigmatized.13,46 Social sup-
port is necessary given that there is a likely increase in psy-
chological distress as HIV infection progresses.31 Future
research can compare these findings using a sample of PLWHA
Table 4. HIV Felt Stigma Impact on Behavioral Outcomes
Variable Nagelkerke R2 B SE Significancea Odds ratio 95% CI
DV: Overall health (poor) 0.201
Public attitudes 0.569 0.310 0.067 1.767 0.96, 3.24
Ostracize 0.128 0.294 0.662 1.137 0.63, 1.86
Discrimination 0.168 0.429 0.695 1.183 0.51, 2.42
Personal life disrupted 0.576 0.278 0.038a 1.779 1.03, 3.22
Depression 1.830 0.381 0.001a 6.234 2.95, 13.16
DV: Disclose serostatus (not disclose) 0.038
Public attitudes 0.225 0.386 0.560 1.252 0.58, 2.66
Ostracize 0.761 0.378 0.044a 2.139 1.02, 4.48
Discrimination - 0.257 0.589 0.662 0.773 0.24, 2.45
Personal life disrupted - 0.643 0.360 0.074 0.525 0.25, 1.06
Depression 0.064 0.464 0.890 1.066 0.42, 2.65
DV: Condom use (not use condom) 0.037
Public attitudes - 0.345 0.285 0.226 0.708 0.40, 1.23
Ostracize - 0.047 0.304 0.877 0.954 0.52, 1.73
Discrimination 0.716 0.458 0.118 2.046 0.83, 5.02
Personal life disrupted - 0.466 0.283 0.100 0.627 0.36, 1.09
Depression 0.387 0.369 0.293 1.473 0.71, 3.03
DV: Medication adherence (not adhere) 0.149
Public attitudes 0.850 0.323 0.008a 2.341 1.24, 4.40
Ostracize 0.083 0.294 0.778 1.086 0.61, 1.93
Discrimination 0.500 0.439 0.255 1.649 0.69, 3.90
Personal life disrupted 0.754 0.281 0.007a 2.125 1.22, 3.68
Depression 0.519 0.361 0.151 1.681 0.82, 3.41
ap < 0.05
6 KINGORI ET AL.
who are not part of an organized HIV care system such as an
HIV clinic, and find out if there would be variability.
While only a fair proportion of participants in the targeted
urban sample reported feelings of stigmatization brought on by
their HIV infection, it does not negate the importance of ag-
gressively addressing HIV stigma in this population in Kenya.
In fact, these findings provide an avenue for HIV interventions
vis-a`-vis clinics serving PLWHA, to develop focused HIV
stigma prevention strategies targeting those PLWHA who
have not yet been able to overcome felt stigma in Kenya albeit
the 2008 HIV stigma strategic plan5 already in place. Particular
attention should be given to the HIV felt stigma dimensions
that emerged as significantly impacting the study’s outcomes.
Limitations
Study findings may only be generalized to individuals living
with HIV/AIDS in the targeted urban city in Kenya and at-
tending an HIV clinic. Second, it is necessary to recognize that
the instrument was researcher administered that may have
influenced socially desirable responses. Third, from a cultural
context, some of the items on the measure related to sexual
activity may have been inappropriate for an older person to
share with an individual young enough to be his or her
daughter, which could have impacted candid responses.
Fourth, even though most participants reported that they ac-
quired HIV infection through heterosexual contact, it may be
necessary to exercise caution in interpreting these findings gi-
ven the limitations associated with self-reported data. Social
desirability could have influenced the responses which may
minimize accurate count of those who may have acquired HIV
via injection drug use or homosexuality given that both activ-
ities are a crime in Kenya. Finally, although the HIV stigma
instrument was deemed culturally relevant based on the psy-
chometric evaluation, it is possible that the contextual items
may not be relevant to all cultures in Kenya given that there are
more than 40 tribes each with its own unique cultural context.
Conclusion
Study findings are useful for HIV clinics and interventions to
provide strategies for PLWHA experiencing felt stigma in order
to enhance the uptake of HIV prevention behaviors. Specifically,
a concentrated effort should address dimensions of HIV felt
stigma that emerged as having an impact on medication ad-
herence, disclosure of serostatus to one other person and overall
health. In order to address the emerging dimensions of HIV felt
stigma effectively, policies in place such as those that identify
high-risk populations from the general population may need to
be revised since they may be enhancing stigma and discrimi-
nation against PLWHA. Such revisions may help enhance
medication adherence, condom use and disclosure of serostatus
such that those who are HIV positive will not be afraid to reveal
their serostatus and thus prevent further HIV transmission to
their sexual partners and have access to social support from
friends, families and the community.
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